Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$0.42 - $0.72 $9,952 - $17,061
23,696 Added 15.44%
177,172 $111,000
Q3 2023

Nov 13, 2023

BUY
$0.6 - $1.53 $14,007 - $35,717
23,345 Added 17.94%
153,476 $92,000
Q2 2023

Aug 10, 2023

BUY
$1.05 - $1.63 $561 - $872
535 Added 0.41%
130,131 $147,000
Q1 2023

May 12, 2023

BUY
$1.2 - $2.73 $1,912 - $4,351
1,594 Added 1.25%
129,596 $174,000
Q4 2022

Feb 10, 2023

BUY
$1.71 - $3.61 $74,667 - $157,630
43,665 Added 51.77%
128,002 $238,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $37,848 - $171,909
-19,920 Reduced 19.11%
84,337 $206,000
Q2 2022

Aug 10, 2022

BUY
$2.13 - $9.01 $59,622 - $252,207
27,992 Added 36.7%
104,257 $254,000
Q1 2022

May 04, 2022

SELL
$6.28 - $15.59 $12,585 - $31,242
-2,004 Reduced 2.56%
76,265 $614,000
Q3 2021

Nov 05, 2021

BUY
$24.31 - $33.6 $614,921 - $849,912
25,295 Added 47.75%
78,269 $2.23 Million
Q2 2021

Aug 02, 2021

SELL
$26.09 - $40.4 $32,951 - $51,025
-1,263 Reduced 2.33%
52,974 $1.79 Million
Q1 2021

May 13, 2021

BUY
$33.06 - $56.93 $785,935 - $1.35 Million
23,773 Added 78.04%
54,237 $2.07 Million
Q4 2020

Feb 10, 2021

SELL
$39.09 - $57.4 $2.35 Million - $3.45 Million
-60,071 Reduced 66.35%
30,464 $1.27 Million
Q3 2020

Nov 12, 2020

BUY
$28.43 - $44.67 $1.31 Million - $2.07 Million
46,234 Added 104.36%
90,535 $3.92 Million
Q2 2020

Aug 14, 2020

SELL
$11.71 - $30.29 $347,798 - $899,643
-29,701 Reduced 40.14%
44,301 $1.34 Million
Q1 2020

May 18, 2020

BUY
$7.64 - $27.5 $565,375 - $2.04 Million
74,002 New
74,002 $577,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.